Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

The Treatment of Hairy Cell Leukemia with a Focus on Long Lasting Responders to Cladribine: A Thirty-Year Experience from the Institute of Hematology of Bologna

Alessandro Broccoli, Carolina Terragna, Vittorio Stefoni, Cinzia Pellegrini, Beatrice Casadei, MD, Miriam Marangon, Alice Morigi, Laura Nanni, MD, Ginevra Lolli, Matteo Carella, Lisa Argnani, Michele Cavo, Pier Luigi Zinzani, MD PhD

Blood (2019) 134 (Supplement_1): 4005.

https://doi.org/10.1182/blood-2019-122832

Published: 2019

Journal Articles

Safety and Efficacy of Allogeneic Hematopoietic Stem Cell Transplant after Programmed Cell Death 1 (PD-1) / Programmed Cell Death Ligand 1 (PD-L1) Blockade for Classical Hodgkin Lymphoma: Analysis of a Large International Cohort

Reid W Merryman, MD, Luca Castagna, MD, Paolo Corradini, MD, Vincent T. Ho, MD, David A. Bond, MD, Samantha Jaglowski, MDMPH, Michael A Spinner, Sally Arai, MD, Robert Lowsky, MD, Alex F. Herrera, MD, Anna Guidetti, MD, Geoffrey Shouse, DO, PhD, Didier Blaise, MD PhD, Jean Marc Schiano De Colella, MD, Talha Badar, MD, Mehdi Hamadani, MD, Stephen M Ansell, MD PhD, Yago Nieto, MD PhD, Chloe Spilleboudt, MD, Tatyana A. Feldman, MD, Lori Dahncke, BSN, Anurag K. Singh, MD, Joseph P. McGuirk, DO, Mohamad Mohty, MD PhD, Remy Dulery, MD, Aspasia Stamatoulas Bastard, Roch Houot, MD PhD, Guillaume Manson, MD, Marie-Pierre Moles, MD, Corentin Orvain, MD, Kamal Bouabdallah, MD, Matthew J. Frigault, MD, Yi-Bin Chen, Ryan C. Lynch, MD, Stephen D. Smith, MD, Uttam Rao, MD, Michael T Byrne, DO, Jason Romancik, MD, Jonathon B. Cohen, MDMS, Robin M. Joyce, MD, Maryam Rahimian, MD, Asad Bashey, MD PhD, Hatcher J. Ballard, BS, Jakub Svoboda, MD, Laura Giordano, Valter Torri, Beatrice Casadei, MD, Martina Sollini, MD, Chiara De Philippis, MD, Massimo Magagnoli, MD, Armando Santoro, Philippe Armand, MD PhD, Pier Luigi Zinzani, MD PhD, Carmelo Carlo-Stella, MD

Blood (2019) 134 (Supplement_1): 775.

https://doi.org/10.1182/blood-2019-125039

Published: 2019

Journal Articles

Azacytidine and Decitabine Exhibit Differential Effects on Cytotoxicity and Methylation and Exhibit Class Synergy with Hdaci in Models of Ptcl

Luigi Scotto, PhD, Cristina Kinahan, B.S., Beatrice Casadei, MD, Owen A. O'Connor, MD, PhD

Blood (2017) 130 (Supplement 1): 2743.

https://doi.org/10.1182/blood.V130.Suppl_1.2743.2743

Published: 2017

Journal Articles

The Bbv Regimen: A Phase II Study with Bendamustine Plus Brentuximab Vedotin in Hodgkin Lymphoma and CD30+ Peripheral T-Cell Lymphoma in First Salvage Setting

Vittorio Stefoni, Beatrice Casadei, MD, Barbara Botto, Paolo Corradini, MD, Antonello Pinto, Alessandro Re, MD, Stefania Badiali, Lisa Argnani, Pier Luigi Zinzani, MD PhD

Blood (2017) 130 (Supplement 1): 4087.

https://doi.org/10.1182/blood.V130.Suppl_1.4087.4087

Published: 2017

Journal Articles

Efficacy and Safety of Biosimilar Epoetin Alpha in Patients with Chronic Lymphoproliferative Syndromes and Chemotherapy-Induced Anemia: An Observational, Retrospective, Monocentric Analysis

Alessandro Broccoli, MD, Beatrice Casadei, MD, Enrico Derenzini, MD, Letizia Gandolfi, MD, Cinzia Pellegrini, Federica Quirini, MD, Vittorio Stefoni, MD, Lisa Argnani, PhD, Pier Luigi Zinzani, MD, PhD

Blood (2014) 124 (21): 5478.

https://doi.org/10.1182/blood.V124.21.5478.5478

Published: 2014

Journal Articles

Langerhans Cell Histiocytosis: A Single Institution Retrospective Analysis of Eleven Patients

Vittorio Stefoni, MD, Alessandro Broccoli, MD, Beatrice Casadei, MD, Enrico Derenzini, MD, Letizia Gandolfi, MD, Cinzia Pellegrini, Federica Quirini, MD, Lisa Argnani, PhD, Pier Luigi Zinzani, MD, PhD

Blood (2014) 124 (21): 5458.

https://doi.org/10.1182/blood.V124.21.5458.5458

Published: 2014

Journal Articles

The Treatment of Primary Mediastinal Large B-Cell Lymphoma: A Two Decades Monocentric Experience on 98 Patients

Beatrice Casadei, MD, Alessandro Broccoli, MD, Vittorio Stefoni, MD, Cinzia Pellegrini, Letizia Gandolfi, MD, Enrico Derenzini, MD, Federica Quirini, MD, Lisa Argnani, PhD, Pier Luigi Zinzani, MD, PhD

Blood (2014) 124 (21): 4440.

https://doi.org/10.1182/blood.V124.21.4440.4440

Published: 2014

Journal Articles

Primary Mediastinal Large B-Cell Lymphoma: Investigation On The Role Of Rituximab and PET During Treatment

Pier Luigi Zinzani, Cinzia Pellegrini, MD, Beatrice Casadei, MD, Enrico Derenzini, MD, Alessandro Broccoli, MD, Letizia Gandolfi, MD, Federica Quirini, MD, Lisa Argnani, PhD, Vittorio Stefoni, MD

Blood (2013) 122 (21): 3046.

https://doi.org/10.1182/blood.V122.21.3046.3046

Published: 2013

Journal Articles

Sequential R-CHOP and R-FM Chemotherapy Followed By Autologous Stem Cell Transplantation Results In High Rates Of Long Term Remission In Advanced Follicular Lymphoma

Enrico Derenzini, MD, Vittorio Stefoni, MD, Beatrice Casadei, MD, Cinzia Pellegrini, MD, Alessandro Broccoli, MD, Stefano Fanti, MD, Letizia Gandolfi, MD, Giulia Stefani, MD, Lisa Argnani, PhD, Pier Luigi Zinzani, MD

Blood (2013) 122 (21): 5543.

https://doi.org/10.1182/blood.V122.21.5543.5543

Published: 2013

Journal Articles

Genomic Instability and Activation Of The DNA Damage Response Pathway Is An Independent Predictor Of Poor Prognosis, Is Associated With MYC Expression and Is a Promising Target For Therapy In Diffuse Large B Cell Lymphoma

Enrico Derenzini, MD, Claudio Agostinelli, MD, Ilaria Iacobucci, PhD, Enrica Imbrogno, Beatrice Casadei, MD, Giovanni Martinelli, MD, Stefano A Pileri, MD, Pier Luigi Zinzani, MD

Blood (2013) 122 (21): 3015.

https://doi.org/10.1182/blood.V122.21.3015.3015

Published: 2013

Journal Articles

Fludarabine, Mitoxantrone and Rituximab (FMR) Regimen in Previously Untreated Patients with Indolent Non-Hodgkin Lymphoma: Efficacy, Safety and PET Data On 285 Patients.

Pier Luigi Zinzani, MD, Cinzia Pellegrini, MD, Enrico Derenzini, MD, Alessandro Broccoli, MD, Letizia Gandolfi, MD, Vittorio Stefoni, MD, Beatrice Casadei, MD, Federica Quirini, MD, Lisa Argnani, PhD

Blood (2012) 120 (21): 2736.

https://doi.org/10.1182/blood.V120.21.2736.2736

Published: 2012

Journal Articles

The Role of Interim-PET and Final-PET in the Outcome of Peripheral T-Cell Lymphoma (PTCL) Treated At the Diagnosis with CHOP.

Cinzia Pellegrini, MD, Beatrice Casadei, MD, Enrico Derenzini, MD, Alessandro Broccoli, MD, Vittorio Stefoni, MD, Letizia Gandolfi, MD, Federica Quirini, MD, Lisa Argnani, PhD, Pier Luigi Zinzani, MD

Blood (2012) 120 (21): 2721.

https://doi.org/10.1182/blood.V120.21.2721.2721

Published: 2012

Journal Articles

Collection of Hematopoietic Stem Cells After Previous Exposure to Ittrium-90 Ibritumumab Tiuxetan (Zevalin) Is Feasible and Does Not Impair Autologous Stem Cell Transplantation Outcome in Follicular Lymphoma.

Enrico Derenzini, MD, Cinzia Pellegrini, MD, Roberto Maglie, Vittorio Stefoni, MD, Alessandro Broccoli, MD, Letizia Gandolfi, MD, Beatrice Casadei, MD, Federica Quirini, MD, Lisa Argnani, PhD, Stefano Fanti, MD, Maria Rosa Motta, PhD, Michele Baccarani, MD, Pier Luigi Zinzani, MD

Blood (2012) 120 (21): 3019.

https://doi.org/10.1182/blood.V120.21.3019.3019

Published: 2012

NARROW

The Treatment of Hairy Cell Leukemia with a Focus on Long Lasting Responders to Cladribine: A Thirty-Year Experience from the Institute of Hematology of Bologna

Safety and Efficacy of Allogeneic Hematopoietic Stem Cell Transplant after Programmed Cell Death 1 (PD-1) / Programmed Cell Death Ligand 1 (PD-L1) Blockade for Classical Hodgkin Lymphoma: Analysis of a Large International Cohort

Azacytidine and Decitabine Exhibit Differential Effects on Cytotoxicity and Methylation and Exhibit Class Synergy with Hdaci in Models of Ptcl

The Bbv Regimen: A Phase II Study with Bendamustine Plus Brentuximab Vedotin in Hodgkin Lymphoma and CD30+ Peripheral T-Cell Lymphoma in First Salvage Setting

Efficacy and Safety of Biosimilar Epoetin Alpha in Patients with Chronic Lymphoproliferative Syndromes and Chemotherapy-Induced Anemia: An Observational, Retrospective, Monocentric Analysis

Langerhans Cell Histiocytosis: A Single Institution Retrospective Analysis of Eleven Patients

The Treatment of Primary Mediastinal Large B-Cell Lymphoma: A Two Decades Monocentric Experience on 98 Patients

Primary Mediastinal Large B-Cell Lymphoma: Investigation On The Role Of Rituximab and PET During Treatment

Sequential R-CHOP and R-FM Chemotherapy Followed By Autologous Stem Cell Transplantation Results In High Rates Of Long Term Remission In Advanced Follicular Lymphoma

Genomic Instability and Activation Of The DNA Damage Response Pathway Is An Independent Predictor Of Poor Prognosis, Is Associated With MYC Expression and Is a Promising Target For Therapy In Diffuse Large B Cell Lymphoma

Fludarabine, Mitoxantrone and Rituximab (FMR) Regimen in Previously Untreated Patients with Indolent Non-Hodgkin Lymphoma: Efficacy, Safety and PET Data On 285 Patients.

The Role of Interim-PET and Final-PET in the Outcome of Peripheral T-Cell Lymphoma (PTCL) Treated At the Diagnosis with CHOP.

Collection of Hematopoietic Stem Cells After Previous Exposure to Ittrium-90 Ibritumumab Tiuxetan (Zevalin) Is Feasible and Does Not Impair Autologous Stem Cell Transplantation Outcome in Follicular Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only